ADVFN - ニュース

S&P 500

5,509.01

0.62%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/03	14 : 06	Alliance News	Anglo American's Australian coal mine battles three-day blaze	LSE:AAL	Anglo American Plc
2024/07/03	14 : 06	Alliance News	Anglo American's Australian coal mine battles three-day blaze	LSE:AAL	Anglo American Plc
2024/07/03	14 : 04	Business Wire	REPAY Announces Pricing of Convertible Notes Offering	NASDAQ:RPAY	Repay Holdings Corporation
2024/07/03	14 : 00	Business Wire	CTP N.V. notice of H1-2024 results
2024/07/03	14 : 00	Business Wire	シカモア・ツリー・キャピタル・パートナーズ「Best US Boutique CLO Manager Award」を受賞
2024/07/03	14 : 00	GlobeNewswire Inc.	Start of Day Message
2024/07/03	14 : 00	Business Wire	Elliptic Labs Signs Expansion Contract with Commercial Segment of PC Customer
2024/07/03	14 : 00	Business Wire	BenevolentAI: Leadership Team Change
2024/07/03	14 : 00	GlobeNewswire Inc.	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	BIT:SANF	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD	NASDAQ:REGN	Regeneron Pharmaceuticals Inc
2024/07/03	14 : 00	GlobeNewswire Inc.	Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne	TG:SNW	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	BIT:1SAN	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne	EU:SAN	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	EU:SAN	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne	BIT:SANF	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne	BIT:1SAN	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	EU:SAN	Sanofi
2024/07/03	14 : 00	GlobeNewswire Inc.	Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD	TG:SNW	Sanofi
2024/07/03	14 : 00	PR Newswire (US)	iTRAK 5750 Intelligent Track System from Rockwell Automation Enables Faster, More Flexible Motion Across Heavier Payloads	NYSE:ROK	Rockwell Automation Inc
2024/07/03	13 : 57	Crypto Briefing	Spot Ethereum ETFs could debut week of July 15, says ETF expert	COIN:ETHUSD	Ethereum
2024/07/03	13 : 28	Alliance News	GLOBAL BRIEFING: Europe called up as Powell revives rate cut hopes
2024/07/03	13 : 19	GlobeNewswire Inc.	Yantai Exhibition Celebrates 27th Anniversary of Hong Kong's Return to Motherland
2024/07/03	13 : 18	NEWSBTC	XRP Price Dip: Should Investors See This as a Buying Chance?	COIN:ETHUSD	Ethereum
2024/07/03	13 : 18	NEWSBTC	XRP Price Dip: Should Investors See This as a Buying Chance?	COIN:BTCUSD	Bitcoin
2024/07/03	13 : 18	NEWSBTC	XRP Price Dip: Should Investors See This as a Buying Chance?	COIN:XRPUSD	Ripple
2024/07/03	13 : 15	PR Newswire (US)	/C O R R E C T I O N -- Wormington & Bollinger/
2024/07/03	13 : 10	PR Newswire (US)	Persistent Acquires Starfish Associates, Strengthening its Position in AI-powered Contact Center and Unified Communications
2024/07/03	13 : 01	PR Newswire (US)	HOME AFFORDABILITY GETS TOUGHER DURING SECOND QUARTER ACROSS U.S. AS PRICES SHOOT BACK UP
2024/07/03	13 : 00	NEWSBTC	ETH Price Dips As Ethereum ETF Approval Faces Delay	COIN:BTCUSD	Bitcoin
2024/07/03	13 : 00	NEWSBTC	ETH Price Dips As Ethereum ETF Approval Faces Delay	COIN:FLOWUSD	Flow